Pricing Log in Create free account

QIAGEN N.V. (QGEN) vs Twist Bioscience Corporation (TWST)

QIAGEN N.V. and Twist Bioscience Corporation are both Diagnostics & Research companies. QIAGEN N.V. and Twist Bioscience Corporation are of similar size ($9.5B and $9.5B). Twist Bioscience Corporation has negative trailing earnings, so its P/E is not meaningful; QIAGEN N.V. trades at 23.6×. Twist Bioscience Corporation grew revenue faster over the last twelve months: 19.2% against 2.96%. QIAGEN N.V. has the higher net margin (19.5% vs −31.7%) and the higher return on invested capital (6.62% vs −30.8%). Across the 19 metrics below, QIAGEN N.V. leads on 16 and Twist Bioscience Corporation on 3.

Valuation

Metric QGEN TWST Diagnostics & Research median
P/E 23.64 n/m 35.56
P/S 4.53 19.18 4.37
P/B 2.83 18.58 3.06
Price to free cash flow 21.60 n/m 35.76
EV/EBITDA 15.93 n/m 24.35
EV/Sales 4.94 18.84 5.51
Earnings yield 4.23% (1.67%) (1.89%)
Free cash flow yield 4.63% (1.15%) (0.15%)

Profitability

Metric QGEN TWST Diagnostics & Research median
Gross margin 62.20% 51.97% 50.89%
Operating margin 21.21% (33.58%) (8.57%)
Net margin 19.49% (31.66%) (6.37%)
Free cash flow margin 20.98% (22.15%) 0.00%
Return on equity 11.93% (29.59%) (2.92%)
Return on assets 6.99% (20.78%) (6.71%)
Return on invested capital 6.62% (30.83%) 0.00%

Growth

Metric QGEN TWST Diagnostics & Research median
Revenue growth (TTM) 2.96% 19.19% 7.69%
EPS growth (last fiscal year) 398.07% 63.89% 25.92%
Revenue growth, 5-year CAGR 2.25% 33.11% 7.40%
Net income growth, 5-year CAGR 3.42% 0.00% 0.00%

Health

Metric QGEN TWST Diagnostics & Research median
Debt to equity 0.49 0.03 0.11
Current ratio 2.85 2.67 2.02
Net debt to EBITDA 0.84 1.95 0.70

Dividend

Metric QGEN TWST Diagnostics & Research median
Dividend yield 0.76% — 0.66%
Payout ratio 0.18 — 0.20

Size

Metric QGEN TWST Diagnostics & Research median
Market cap 9.51b 9.51b 2.16b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack